A comprehensive review on Pueraria: Insights on its chemistry and medicinal value

Biomedicine and Pharmacotherapy

Volumn 131, Issue , 2020, Pages

  Wang, Shengguang ^a   Zhang, Shiming ^a   Wang, Shaoping ^b   Gao, Peng ^a   Dai, Long ^b  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Binzhou Medical University   (China)

Author keywords

Alcohol abuse; Isoflavones; Kudzu; Phytoestrogens; Pueraria; Puerarin

Indexed keywords

ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIPYRETIC AGENT; BONE DENSITY CONSERVATION AGENT; CARDIAC AGENT; CHEMICAL COMPOUND; COSMETIC; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; ISOFLAVONE DERIVATIVE; LIVER PROTECTIVE AGENT; MUSCLE RELAXANT AGENT; MUTAGENIC AGENT; NEUROPROTECTIVE AGENT; PUERARIN; ANTIOXIDANT; PLANT EXTRACT;

ALCOHOLISM; ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOSTEOPOROTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; BACKACHE; BIOLOGICAL ACTIVITY; CEREBROVASCULAR ACCIDENT; CHEMICAL STRUCTURE; CHEMOTAXONOMY; CHINESE MEDICINE; CLINICAL STUDY; DIARRHEA; DIZZINESS; DRUG ACTIVITY; DRUG SAFETY; DRUG SYNTHESIS; DYSENTERY; ESTROGEN ACTIVITY; FEVER; HEADACHE; HEART PROTECTION; HELICOBACTER PYLORI; HEMIPLEGIA; HEMOLYSIS; HERBAL MEDICINE; IMMUNOMODULATION; INFORMATION RETRIEVAL; LIVER PROTECTION; MEASLES; MEDLINE; MUTAGENIC ACTIVITY; NEUROPROTECTION; NONHUMAN; PHARMACOKINETIC PARAMETERS; PLANT TUBER; POSTMENOPAUSE; PRIORITY JOURNAL; PUERARIA; PUERARIA LOBATA; RASH; RENAL PROTECTION; REVIEW; SCOPUS; THORAX PAIN; WEB OF SCIENCE; ANIMAL; CHEMISTRY; DIABETES MELLITUS; HUMAN; NEOPLASM; OSTEOPOROSIS; PHYTOTHERAPY; TOXIC HEPATITIS;

ALCOHOLISM; ANIMALS; ANTIOXIDANTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIABETES MELLITUS; HUMANS; NEOPLASMS; NEUROPROTECTIVE AGENTS; OSTEOPOROSIS; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; PUERARIA;

EID: 85090705628     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2020.110734     Document Type: Review

References (84)

1. Tungmunnithum, D., Intharuksa, A., Sasaki, Y., A Promising View of Kudzu Plant, Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: Flavonoid Phytochemical Compounds, Taxonomic Data, Traditional Uses and Potential Biological Activities for Future Cosmetic Application. Cosmetics, 7, 2020, 12.
2. Xiong, Y., Yang, Y., Yang, J., Chai, H., Li, Y., Yang, J., Jia, Z., Wang, Z., Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology 276 (2010), 64–72.
3. Yuan, D., Xie, Y.-Y., Bai, X., Wu, X., Yang, J.-Y., Wu, C.-F., Inhibitory activity of isoflavones of Pueraria flowers on nitric oxide production from lipopolysaccharide-activated primary rat microglia. J. Asian Nat. Prod. Res. 11 (2009), 471–481.
4. Lin, R.C., Guthrie, S., Xie, C.Y., Mai, K., Lee, D.Y., Lumeng, L., Li, T.K., Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol. Clin. Exp. Res. 20 (1996), 659–663.
5. Son, E., Yoon, J.-M., An, B.-J., Lee, Y.M., Cha, J., Chi, G.-Y., Kim, D.-S., Comparison among Activities and Isoflavonoids fromPueraria thunbergiana Aerial Parts and Root. Molecules, 24, 2019.
6. Gao, Y., Wang, X., He, C., An isoflavonoid-enriched extract from Pueraria lobata (kudzu) root protects human umbilical vein endothelial cells against oxidative stress induced apoptosis. J. Ethnopharmacol. 193 (2016), 524–530.
7. Viji, Zereena, Paulsamy, N-vitro antioxidant properties and total phenolic, flavonoid and tannin contents of Pueraria tuberosa (Roxb. Ex willd.) DC. Res. J. Pharm., Biol. Chem. Sci. 6 (2015), 1202–1209.
8. Jearapong, N., Chatuphonprasert, W., Jarukamjorn, K., Miroestrol, a phytoestrogen from Pueraria mirifica, improves the antioxidation state in the livers and uteri of beta-naphthoflavone-treated mice. J. Nat. Med. 68 (2014), 173–180.
9. Chatuphonprasert, W., Udomsuk, L., Monthakantirat, O., Churikhit, Y., Putalun, W., Jarukamjorn, K., Effects of Pueraria mirifica and miroestrol on the antioxidation-related enzymes in ovariectomized mice. J. Pharm. Pharmacol. 65 (2013), 447–456.
10. Zhang, B., Li, W., Dong, M., Flavonoids of kudzu root fermented by eurtotium cristatum protected rat pheochromocytoma line 12 (PC12) cells against H(2)O(2)-Induced apoptosis. Int. J. Mol. Sci., 18, 2017.
11. Jin, S.E., Son, Y.K., Min, B.-S., Jung, H.A., Choi, J.S., Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. Arch. Pharm. Res. 35 (2012), 823–837.
12. Sucontphunt, A., De-Eknamkul, W., Nimmannit, U., Dan Dimitrijevich, S., Gracy, R.W., Protection of HT22 neuronal cells against glutamate toxicity mediated by the antioxidant activity of Pueraria candollei var. Mirifica extracts. J. Nat. Med. 65 (2011), 1–8.
13. Bebrevska, L., Foubert, K., Hermans, N., Chatterjee, S., Van Marck, E., De Meyer, G., Vlietinck, A., Pieters, L., Apers, S., In vivo antioxidative activity of a quantified Pueraria lobata root extract. J. Ethnopharmacol. 127 (2010), 112–117.
14. Yu, H.-H., Jung, S.-Y., Shin, M.-K., Park, R., So, H.-S., You, Y.-O., Pueraria thunbergiana inhibits cisplatin-induced damage of HEI-OC1 auditory cells through scavenging free radicals. Phytother. Res. 24 (2010), 834–839.
15. Cherdshewasart, W., Sutjit, W., Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica and Pueraria lobata tubers. Phytomedicine 15 (2008), 38–43.
16. Jiang, R.-W., Lau, K.-M., Lam, H.-M., Yam, W.-S., Leung, L.-K., Choi, K.-L., Waye, M.M.Y., Mak, T.C.W., Woo, K.-S., Fung, K.-P., A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J. Ethnopharmacol. 96 (2005), 133–138.
17. Xu, L., Zheng, N., He, Q., Li, R., Zhang, K., Liang, T., Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-beta1/Smad signaling pathway, thereby leading to anti-fibrotic effect. Phytomedicine 20 (2013), 1172–1179.
18. Arao, T., Udayama, M., Kinjo, J., Nohara, T., Funakoshi, T., Kojima, S., Preventive effects of saponins from puerariae radix (the root of Pueraria lobata Ohwi) on in vitro immunological injury of rat primary hepatocyte cultures. Biol. Pharm. Bull. 20 (1997), 988–991.
19. Arao, T., Udayama, M., Kinjo, J., Nohara, T., Preventive effects of saponins from the Pueraria lobata root on in vitro immunological liver injury of rat primary hepatocyte cultures. Planta Med. 64 (1998), 413–416.
20. Shukla, S., Jonathan, S., Sharma, A., Protective action of butanolic extract of Pueraria tuberosa DC. Against carbon tetrachloride induced hepatotoxicity in adult rats. Phyther. Res. 10 (1996), 608–609.
21. Santosh, N., Mohan, K., Royana, S., Yamini, T.B., Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats. Food Chem. Toxicol. 48 (2010), 1066–1071.
22. Gupta, R.S., Sharma, R., Sharma, A., Choudhary, R., Bhatnager, A.K., Joshi, Y.C., Antifertility Effects of Pueraria tuberosa root extract in mle rats. Pharm. Biol. 42 (2005), 603–609.
23. Malaivijitnond, S., Kiatthaipipat, P., Cherdshewasart, W., Watanabe, G., Taya, K., Different effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J. Pharmacol. Sci. 96 (2004), 428–435.
24. Shukla, S., Post‐coital Contraceptive Action of Pueraria tuberosaDC. Extract in Rats. Phyther. Res. 10 (1996), 95–99.
25. Sun, R., Deng, X., Zhang, D., Xie, F., Wang, D., Wang, J., Tavallaie, M.S., Jiang, F., Fu, L., Anti-diabetic potential of Pueraria lobata root extract through promoting insulin signaling by PTP1B inhibition. Bioorg. Chem. 87 (2019), 12–15.
26. Wang, X.L., Jiao, F.R., Yu, M., Bin Lin, L., Xiao, J., Zhang, Q., Wang, L., Duan, D.Z., Xie, G., Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi. Bioorganic Med. Chem. Lett. 27 (2017), 1993–1998.
27. Shukla, R., Pandey, N., Banerjee, S., Tripathi, Y.B., Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats. Biomed. Pharmacother. 93 (2017), 276–285.
28. Seong, S.H., Roy, A., Jung, H.A., Jung, H.J., Choi, J.S., Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents. J. Ethnopharmacol. 194 (2016), 706–716.
29. Srivastava, S., Koley, T.K., Singh, S.K., Tripathi, Y.B., The tuber extract of pueraria tuberosa Linn. competitively inhibits DPP-IV activity in normoglycemic rats. Int. J. Pharm. Pharm. Sci. 7 (2015), 227–231.
30. Wu, K., Liang, T., Duan, X., Xu, L., Zhang, K., Li, R., Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. Food Chem. Toxicol. 60 (2013), 341–347.
31. Prasain, J.K., Peng, N., Rajbhandari, R., Wyss, J.M., The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice. Phytomedicine. 20 (2012), 17–23.
32. Kim, J.M., Lee, Y.M., Lee, G.Y., Jang, D.S., Bae, K.H., Kim, J.S., Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs). Arch. Pharm. Res. 29 (2006), 821–825.
33. Jang, D.S., Kim, J.M., Lee, Y.M., Kim, Y.S., Kim, J.-H., Kim, J.S., Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. (Tokyo). 54 (2006), 1315–1317.
34. Kim, N.H., Kim, Y.S., Lee, Y.M., Jang, D.S., Kim, J.S., Inhibition of aldose reductase and xylose-induced lens opacity by puerariafuran from the roots of Pueraria lobata. Biol. Pharm. Bull. 33 (2010), 1605–1609.
35. Zhu, G., Wang, X., Chen, Y., Yang, S., Cheng, H., Wang, N., Li, Q., Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med. 76 (2010), 1820–1826.
36. Cheng, Y.F., Zhu, G.Q., Wang, M., Cheng, H., Zhou, A., Wang, N., Fang, N., Wang, X.C., Xiao, X.Q., Chen, Z.W., Li, Q.L., Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP+-elicited apoptosis. Neurosci. Res. 63 (2009), 52–58.
37. Koirala, P., Seong, S.H., Jung, H.A., Choi, J.S., Comparative evaluation of the antioxidant and anti-Alzheimer's disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling studies. Molecules 23 (2018), 1–15.
38. Koirala, P., Seong, S.H., Jung, H.A., Choi, J.S., Comparative molecular docking studies of lupeol and lupenone isolated from Pueraria lobata that inhibits BACE1: probable remedies for Alzheimer's disease, Asian Pac. J. Trop. Med. 10 (2017), 1117–1122.
39. Xiao, B., Sun, Z., Cao, F., Wang, L., Liao, Y., Liu, X., Pan, R., Chang, Q., Brain pharmacokinetics and the pharmacological effects on striatal neurotransmitter levels of Pueraria lobata isoflavonoids in rat. Front. Pharmacol., 8, 2017.
40. Anukulthanakorn, K., Parhar, I.S., Jaroenporn, S., Kitahashi, T., Watanbe, G., Malaivijitnond, S., Neurotherapeutic effects of Pueraria mirifica extract in early- and late-stage cognitive impaired rats. Phyther. Res. 30 (2016), 929–939.
41. Cho, H.J., Jun, H., Lee, J.H., Jia, Y., Hoang, M.H., Shim, J.-H., Park, K.-H., Lee, S.-J., Acute effect of high-dose isoflavones from Pueraria lobata (Willd.) Ohwi on lipid and bone metabolism in ovariectomized mice. Phytother. Res. 26 (2012), 1864–1871.
42. Choi, Y., Hong, S.S., Shin, Y.S., Hwang, B.Y., Park, S.-Y., Lee, D., Phenolic compounds from Pueraria lobata protect PC12 cells against Abeta-induced toxicity. Arch. Pharm. Res. 33 (2010), 1651–1654 7.
43. Lee, C.M., Yoon, M.S., Kim, Y.C., Effects of Pueraria lobata root ethanol extract on adipogenesis and lipogenesis during 3T3-L1 differentiation into adipocytes. Toxicol. Res. 31 (2015), 191–201.
44. Min, S.-W., Kim, D.-H., Kakkalide and irisolidone: HMG-CoA reductase inhibitors isolated from the flower of Pueraria thunbergiana. Biol. Pharm. Bull. 30 (2007), 1965–1968.
45. Yadav, D., Kumar, M., Tripathi, Y.B., Methanolic extract of tubers of Pueraria tuberosa Linn. ameliorates glycerol induced acute kidney injury in rats. J. Chem. Pharm. Res. 8 (2016), 133–139.
46. Tripathi, Y.B., Nagwani, S., Mishra, P., Jha, A., Rai, S.P., Protective effect of Pueraria tuberosaDC. embedded biscuit on cisplatin-induced nephrotoxicity in mice. J. Nat. Med. 66 (2012), 109–118.
47. Sumalatha, M., Munikishore, R., Rammohan, A., Gunasekar, D., Kumar, K.A., Reddy, K.K., Azad, R., Reddanna, P., Bodo, B., Isoorientin, a selective inhibitor of cyclooxygenase-2 (COX-2) from the tubers of pueraria tuberosa. Nat. Prod. Commun. 10 (2015), 1703–1704.
48. Shukla, R., Banerjee, S., Tripathi, Y.B., Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-α and NF-kB pathway in diabetes-induced nephropathy. J. Pharm. Pharmacol. 70 (2018), 1102–1112.
49. Lim, D.W., Lee, C., Kim, I.-H., Kim, Y.T., Anti-inflammatory effects of total isoflavones from Pueraria lobata on cerebral ischemia in rats. Molecules 18 (2013), 10404–10412.
50. Quan, S., Wang, J.-B., Xia, X.-P., Lin, X.-A., Yan, J., Protective effect of puerarin form the roots of Pueraria lobata against systemic inflammatory response syndrome by regulating the levels of related cytokines. J. Med. Plants Res. 5 (2011), 2917–2921.
51. Lee, S.J., Baek, H.J., Lee, C.H., Kim, H.P., Anti-inflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch. Pharm. Res. 17 (1994), 31–35.
52. Yasuda, T., Endo, M., Kon-no, T., Kato, T., Mitsuzuka, M., Ohsawa, K., Antipyretic, analgesic and muscle relaxant activities of pueraria isoflavonoids and their metabolites from Pueraria lobata Ohwi-a traditional Chinese drug. Biol. Pharm. Bull. 28 (2005), 1224–1228.
53. Cherdshewasart, W., Sutjit, W., Pulcharoen, K., Chulasiri, M., The mutagenic and antimutagenic effects of the traditional phytoestrogen-rich herbs, Pueraria mirifica and Pueraria lobata. Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. Medicas e Biol. 42 (2009), 816–823.
54. Park, K.-Y., Jung, G.-O., Choi, J., Lee, K.-T., Park, H.-J., Potent antimutagenic and their anti-lipid peroxidative effect of kaikasaponin III and tectorigenin from the flower of Pueraria thunbergiana. Arch. Pharm. Res. 25 (2002), 320–324.
55. Maji, A.K., Mahapatra, S., Banerjee, D., In-vivo immunomodulatory potential of standardized pueraria tuberosa extract and its isoflavonoids. Int. J. Pharm. Pharm. Sci. 6 (2014), 861–867.
56. Oh, S.R., Kinjo, J., Shii, Y., Ikeda, T., Nohara, T., Ahn, K.S., Kim, J.H., Lee, H.K., Effects of triterpenoids from Pueraria lobata on immunohemolysis: beta-D-glucuronic acid plays an active role in anticomplementary activity in vitro. Planta Med. 66 (2000), 506–510.
57. Bae, E.A., Han, M.J., Kim, D.H., In vitro anti-Helicobacter pylori activity of irisolidone isolated from the flowers and rhizomes of Pueraria thunbergiana. Planta Med. 67 (2001), 161–163.
58. Mocan, A., Carradori, S., Locatelli, M., Secci, D., Cesa, S., Mollica, A., Riga, S., Angeli, A., Supuran, C.T., Celia, C., Di Marzio, L., Bioactive isoflavones from Pueraria lobata root and starch: different extraction techniques and carbonic anhydrase inhibition. Food Chem. Toxicol. 112 (2018), 441–447.
59. van Kuijk, S.J.A., Parvathaneni, N.K., Niemans, R., van Gisbergen, M.W., Carta, F., Vullo, D., Pastorekova, S., Yaromina, A., Supuran, C.T., Dubois, L.J., Winum, J.Y., Lambin, P., New approach of delivering cytotoxic drugs towards CAIX expressing cells: a concept of dual-target drugs. Eur. J. Med. Chem. 127 (2017), 691–702.
60. Durgawale, T.P., Durgawale, P.P., Khanwelkar, C.C., In vitro study of cytotoxic activity of the different extracts of the tubers of Pueraria tuberosa. Der Pharm. Lett. 8 (2016), 337–340.
61. Cherdshewasart, W., Cheewasopit, W., Picha, P., The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. J. Ethnopharmacol. 93 (2004), 255–260.
62. Lee, K.T., Sohn, I.C., Kim, Y.K., Choi, J.H., Choi, J.W., Park, H.J., Itoh, Y., Miyamoto, K., Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol. Pharm. Bull. 24 (2001), 1117–1121.
63. Ahn, S.-Y., Jo, M.S., Lee, D., Baek, S.-E., Baek, J., Yu, J.S., Jo, J., Yun, H., Kang, K.S., Yoo, J.-E., Kim, K.H., Dual effects of isoflavonoids from Pueraria lobata roots on estrogenic activity and anti-proliferation of MCF-7 human breast carcinoma cells. Bioorg. Chem. 83 (2019), 135–144.
64. Kakehashi, A., Yoshida, M., Tago, Y., Ishii, N., Okuno, T., Gi, M., Wanibuchi, H., Pueraria mirifica exerts estrogenic effects in the mammary gland and uterus and promotes mammary carcinogenesis in donryu rats. Toxins (Basel)., 8, 2016.
65. Tiyasatkulkovit, W., Charoenphandhu, N., Wongdee, K., Thongbunchoo, J., Krishnamra, N., Malaivijitnond, S., Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica. Phytomedicine. 19 (2012), 1147–1155.
66. Udomsuk, L., Chatuphonprasert, W., Monthakantirat, O., Churikhit, Y., Jarukamjorn, K., Impact of Pueraria candollei var. Mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. Fitoterapia. 83 (2012), 1687–1692.
67. Sookvanichsilp, N., Soonthornchareonnon, N., Boonleang, C., Estrogenic activity of the dichloromethane extract from Pueraria mirifica. Fitoterapia. 79 (2008), 509–514.
68. Suthon, S., Jaroenporn, S., Charoenphandhu, N., Suntornsaratoon, P., Malaivijitnond, S., Anti-osteoporotic effects of Pueraria candollei var. Mirifica on bone mineral density and histomorphometry in estrogen-deficient rats. J. Nat. Med. 70 (2016), 225–233.
69. Manonai, J., Chittacharoen, A., Theppisai, U., Theppisai, H., Effect of Pueraria mirifica on vaginal health. Menopause 14 (2007), 919–924.
70. Manonai, J., Chittacharoen, A., Udomsubpayakul, U., Theppisai, H., Theppisai, U., Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 15 (2008), 530–535.
71. Virojchaiwong, P., Suvithayasiri, V., Itharat, A., Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms. Arch. Gynecol. Obstet. 284 (2011), 411–419.
72. Chandeying, V., Sangthawan, M., Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. J. Med. Assoc. Thai. 90 (2007), 1720–1726.
73. Lamlertkittikul, S., Chandeying, V., Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: phase II study. J. Med. Assoc. Thai. 87 (2004), 33–40.
74. Chandeying, V., Lamlertkittikul, S., Challenges in the conduct of Thai herbal scientific study: Efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. J. Med. Assoc. Thai. 90 (2007), 1274–1280.
75. Okamura, S., Sawada, Y., Satoh, T., Sakamoto, H., Saito, Y., Sumino, H., Takizawa, T., Kogure, T., Chaichantipyuth, C., Higuchi, Y., Ishikawa, T., Sakamaki, T., Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J. Exp. Med. 216 (2008), 341–351.
76. Suwanvesh, N., Manonai, J., Sophonsritsuk, A., Cherdshewasart, W., Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause 24 (2017), 210–215.
77. Kamiya, T., Takano, A., Matsuzuka, Y., Kusaba, N., Ikeguchi, M., Takagaki, K., Kondo, K., Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans. Biosci. Biotechnol. Biochem. 76 (2012), 1511–1517.
78. Yamazaki, T., Hosono, T., Matsushita, Y., Kawashima, K., Someya, M., Nakajima, Y., Narui, K., Hibi, Y., Ishizaki, M., Kinjo, J., Nohara, T., Pharmacological studies on Puerariae Flos IV: effects of Pueraria thomsonii dried flower extracts on blood ethanol and acetaldehyde levels in humans. Int. J. Clin. Pharmacol. Res. 22 (2002), 23–28.
79. Verma, S.K., Jain, V., Singh, D.P., Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension. Pak. J. Biol. Sci. 15 (2012), 742–747.
80. Woo, J., Lau, E., Ho, S.C., Cheng, F., Chan, C., Chan, A.S.Y., Haines, C.J., Chan, T.Y.K., Li, M., Sham, A., Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 10 (2003), 352–361.
81. Tam, W.Y., Chook, P., Qiao, M., Chan, L.T., Chan, T.Y.K., Poon, Y.K., Fung, K.P., Leung, P.C., Woo, K.S., The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. J. Altern. Complement. Med. 15 (2009), 415–421.
82. Wu, T., Gu, N., Wang, F., [Effect of ningxintong granule in treating patients of coronary heart disease with left ventricular diastolic dysfunction and qi-deficiency blood-stasis syndrome]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese J. Integr. Tradit. West. Med. 30 (2010), 357–360.
83. Yeh, T.-S., Chan, K.-H., Hsu, M.-C., Liu, J.-F., Supplementation with soybean peptides, taurine, Pueraria isoflavone, and ginseng saponin complex improves endurance exercise capacity in humans. J. Med. Food 14 (2011), 219–225.
84. Heo, S.H., Song, J., Kim, B.J., Kim, H., Il Chang, D., Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial. Med. (United States)., 98, 2019.